RECURRENT PLASMABLASTIC LYMPHOMA
Clinical trials for RECURRENT PLASMABLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMABLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMABLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental antibody takes aim at Hard-to-Treat lymphoma
Disease control Recruiting nowThis early-phase trial tests a drug called teclistamab in 30 adults with plasmablastic lymphoma that has returned or not responded to prior treatment. Teclistamab is a bispecific antibody designed to attach to both cancer cells and immune T-cells, helping the immune system attack…
Matched conditions: RECURRENT PLASMABLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Scientists seek tissue samples to unlock HIV-Cancer mysteries
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 200 adults with HIV and certain cancers (like Kaposi sarcoma, lymphoma, or anal cancer) to help researchers understand how HIV and cancer are connected. Participants donate samples, which are stored for future research. There is n…
Matched conditions: RECURRENT PLASMABLASTIC LYMPHOMA
Sponsor: AIDS Malignancy Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC